Skip header and navigation

Refine By

7 records – page 1 of 1.

Ally, advocate, analyst, agenda-setter? Positions and perceptions of Swedish medical journalists.

https://arctichealth.org/en/permalink/ahliterature72803
Source
Patient Educ Couns. 1997 Jan;30(1):71-81
Publication Type
Article
Date
Jan-1997
Author
D. Finer
G. Tomson
N M Björkman
Author Affiliation
Department of Public Health Sciences, Karolinska Institutet, Stockholm, Sweden.
Source
Patient Educ Couns. 1997 Jan;30(1):71-81
Date
Jan-1997
Language
English
Publication Type
Article
Keywords
Attitude to Health
Diffusion of Innovation
Female
Health education
Humans
Interprofessional Relations
Journalism, Medical
Male
Middle Aged
Patient Advocacy
Questionnaires
Research Support, Non-U.S. Gov't
Role
Sweden
Abstract
Medical journalists in the mass media play a key role in health information dissemination and risk/benefit education. Public education on the rational use of various health technologies, e.g. pharmaceuticals, is increasingly important as part of ongoing global health sector reforms. In a survey of 110 Swedish medical journalists (55% response rate) about medicinal drugs, risk perceptions and professional concerns, fact-giving, stimulating, and critical functions were rated as the most important journalist role attributes, followed by advocacy of patient interests and of public health goals. Major perceived problems were self-imposed professional demands, job stress, knowledge and time constraints, and selection and contextualization of news material. In terms of medicinal drugs, attitudes were strongly in favor of a unique drug information role for the media and critical of physician prescribing and information-giving. Views on the appropriateness of specific ethical rules or guidelines for medical journalists were sharply divided. The results offer some promise for increased alliance-building between public health and the mass media.
PubMed ID
9110834 View in PubMed
Less detail

[Infectious diseases in the press. A Danish communication discloses the irrationality of the mass media]

https://arctichealth.org/en/permalink/ahliterature7692
Source
Lakartidningen. 1998 Jan 28;95(5):410-5
Publication Type
Article
Date
Jan-28-1998
Author
D. Finer
Source
Lakartidningen. 1998 Jan 28;95(5):410-5
Date
Jan-28-1998
Language
Swedish
Publication Type
Article
Keywords
Denmark
Disease Outbreaks
HIV Infections - epidemiology
Humans
Infection - epidemiology
Journalism, Medical
Mass Media
Newspapers
PubMed ID
9492490 View in PubMed
Less detail

[Patients with diabetes search facts about their disease on the net. More information in Swedish is needed]

https://arctichealth.org/en/permalink/ahliterature47970
Source
Lakartidningen. 1999 Jun 16;96(24):2970-4
Publication Type
Article
Date
Jun-16-1999

[Refugees who had been exposed to torture--a reality in the Swedish society].

https://arctichealth.org/en/permalink/ahliterature232040
Source
Lakartidningen. 1988 Dec 7;85(49):4332-3, 4337-8
Publication Type
Article
Date
Dec-7-1988
Author
D. Finer
Source
Lakartidningen. 1988 Dec 7;85(49):4332-3, 4337-8
Date
Dec-7-1988
Language
Swedish
Publication Type
Article
Keywords
Humans
Psychotherapy
Refugees - psychology
Sweden
Torture
PubMed ID
3200056 View in PubMed
Less detail

[Smokeless occupational environment--human right or patronizing?]

https://arctichealth.org/en/permalink/ahliterature67802
Source
Lakartidningen. 1993 Feb 10;90(6):438, 443-6
Publication Type
Article
Date
Feb-10-1993

[Swedish physicians and social workers in a fight for free syringes for narcotic addicts]

https://arctichealth.org/en/permalink/ahliterature8523
Source
Nord Med. 1989;104(8-9):227
Publication Type
Article
Date
1989

Workplace drug testing (WDT) likely to increase in Europe. Report from the First European Symposium on WDT including selected abstracts.

https://arctichealth.org/en/permalink/ahliterature10436
Source
Eur J Clin Pharmacol. 2000 Apr;56(1):103-20
Publication Type
Conference/Meeting Material
Date
Apr-2000
Author
P. Dalén
O. Beck
U. Bergman
P. Björklöv
D. Finer
M. Garle
F. Sjöqvist
Author Affiliation
Department of Medical Laboratory Sciences and Technology, Karolinska Institute at Huddinge University Hospital, Sweden.
Source
Eur J Clin Pharmacol. 2000 Apr;56(1):103-20
Date
Apr-2000
Language
English
Publication Type
Conference/Meeting Material
Keywords
Europe - epidemiology
Humans
Substance Abuse Detection - legislation & jurisprudence - methods
Workplace - legislation & jurisprudence
Abstract
Will it take a series of drug-related accidents that have already occurred in the USA before workplace drug testing (WDT) becomes accepted in Europe as a preventive measure? Currently, the development of WDT in most European countries lags some 10-15 years behind that in the USA. Labour authorities in Europe now ought to take initiatives to demand a mandatory programme for accrediting drug analytical laboratories for WDT. Companies should realise that illicit drug use is no longer only a problem at street corners, and that having a testing system in place is important, not just for public health, but also for their reputations as responsible societal actors. Improved networking among police and regulatory authorities is required to keep pace with the rapid appearance and dissemination of new substances of abuse. European research collaboration, including the newly formed European Workplace Drug Testing Group, is needed to assess the impact of drug-testing policies on accidents and other outcome variables, and thereby to convince the general public and politicians that drug testing is beneficial and necessary. A 1993-1994 survey of quality analysis in some 200 European laboratories reported from Institut Municipal d'Investigació Medica (IMIM), Spain, showed good agreement between nominal and found concentrations but that only 10% of the laboratories could both screen, identify and quantify samples. Experiences from Italy show that proficiency testing schemes lead to improved accuracy of results. These were some major conclusions of the First European Symposium on Drug Testing held at Huddinge University Hospital in Stockholm, Sweden, 30 March to 1 April 1998, organised by Karolinska Institute, with participants from 22 countries.
PubMed ID
10853886 View in PubMed
Less detail

7 records – page 1 of 1.